Iceland Screens, Treats or Prevents Multiple Myeloma

Participants receive routine care outside the bounds of the trial. No further work-up.

Participants receive a Mental Health and Quality of Life questionnaire that will be answered electronically on the study website (www.blodskimun.is)

Participants previously diagnosed as having MGUS or participants that have multiple myeloma or other lymphoproliferative diseases will receive standard clinical follow-up and treatment.

Standard clinical follow-up according to International Myeloma Working Group (IMWG) guidelines.

Intensive clinical follow-up with regular clinical assessment, laboratory testing and radiology imaging.

Control clinical visit